Thiola 100 MG

Ended Awarded

Contract number
36C24524N0760
Awardee
Awarding agency
Obligated
$11,125

Award facts

Contract value 100% obligated
$11,125.32 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92130, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the delivery of Thiola 100 mg, a medication produced by Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract, valued at $11,125.32, was awarded by the Veterans Integrated Service Network 5 (VISN 5) of the Department of Veterans Affairs (VA) on July 25, 2024. It is a firm fixed-price delivery order contract, with a completion date of July 26, 2024.

The contract is placed under Travere Therapeutics' Federal Supply Schedule (FSS) contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $14,970,593.10. Travere Therapeutics also holds two $25 million Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center for the procurement of Thiola and Cholbam, another Travere product. These contracting vehicles demonstrate Travere's role as a key supplier of rare disease medications to the VA healthcare system, which serves over 9 million enrolled veterans.

Quick answers

Who was awarded contract 36C24524N0760?

36C24524N0760 was awarded to Travere Therapeutics, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on July 25, 2024.

How much is contract 36C24524N0760 worth?

The government has obligated $11,125 on 36C24524N0760.

Is contract 36C24524N0760 an order under another contract?

Yes. 36C24524N0760 is a delivery order under 36F79721D0239, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24524N0760 competed?

The extent of competition for 36C24524N0760 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award